Why is Exagen, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate 3.42% of over the last 5 years
2
Flat results in Sep 25
- ROCE(HY) Lowest at -122.81%
- INTEREST(Q) Highest at USD 1.32 MM
- EPS(Q) Lowest at USD -0.31
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -32.35%, its profits have risen by 7.6%
4
Below par performance in long term as well as near term
- Along with generating -32.35% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Exagen, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Exagen, Inc.
-28.89%
0.58
65.07%
S&P 500
13.68%
0.71
19.28%
Quality key factors
Factor
Value
Sales Growth (5y)
9.98%
EBIT Growth (5y)
3.42%
EBIT to Interest (avg)
-9.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.70
Sales to Capital Employed (avg)
1.42
Tax Ratio
0.08%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
59.51%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.19
EV to EBIT
-5.26
EV to EBITDA
-6.22
EV to Capital Employed
8.46
EV to Sales
1.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-160.94%
ROE (Latest)
-86.21%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Movement
9What is working for the Company
NET PROFIT(HY)
Higher at USD -8.12 MM
NET SALES(Q)
Highest at USD 17.24 MM
RAW MATERIAL COST(Y)
Fallen by -4.76% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -41.27 %
DEBTORS TURNOVER RATIO(HY)
Highest at 6.21 times
-13What is not working for the Company
ROCE(HY)
Lowest at -122.81%
INTEREST(Q)
Highest at USD 1.32 MM
EPS(Q)
Lowest at USD -0.31
Here's what is working for Exagen, Inc.
Net Sales
Highest at USD 17.24 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -8.12 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Sales
At USD 17.24 MM has Grown at 17.18%
over average net sales of the previous four periods of USD 14.72 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Debt-Equity Ratio
Lowest at -41.27 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 6.21 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -4.76% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Exagen, Inc.
Interest
At USD 1.32 MM has Grown at 17.35%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest
Highest at USD 1.32 MM
in the last five periods and Increased by 17.35% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
EPS
Lowest at USD -0.31
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)






